A business in context

NRXP research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-10-20 · 8029 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 8-K · Current report

    Report date 2026-10-16 · 0001437749-26-032828 · Items 8.01,9.01

  2. 8-K · Current report

    Report date 2026-09-29 · 0001437749-26-032042 · Items 1.01,9.01

  3. 8-K · Current report

    Report date 2026-09-15 · 0001437749-26-030492 · Items 8.01,9.01

  4. 8-K · Current report

    Report date 2026-09-08 · 0001437749-26-030228 · Items 7.01,9.01

  5. 8-K · Current report

    Report date 2026-08-17 · 0001437749-26-028111 · Items 2.02,9.01

  6. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001437749-26-028027

  7. 8-K · Current report

    Report date 2026-08-07 · 0001437749-26-026428 · Items 7.01

  8. 8-K · Current report

    Report date 2026-07-21 · 0001437749-26-024037 · Items 8.01

  9. 8-K · Current report

    Report date 2026-06-03 · 0001437749-26-019576 · Items 1.01,8.01,9.01

  10. 8-K · Current report

    Report date 2026-06-02 · 0001437749-26-019196 · Items 8.01,9.01

  11. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001437749-26-017397

  12. 8-K · Current report

    Report date 2026-03-23 · 0001437749-26-009611 · Items 5.02,5.07,9.01

  13. 10-K · Annual report

    Report date 2025-12-31 · 0001437749-26-009418

  14. DEF 14A · Proxy statement

    Report date 2026-03-23 · 0001437749-26-005119

  15. 4 · Ownership change

    Report date 2026-01-27 · 0001437749-26-004426

  16. 8-K · Current report

    Report date 2026-02-17 · 0001437749-26-004246 · Items 8.01,9.01

  17. 8-K · Current report

    Report date 2026-02-17 · 0001437749-26-004245 · Items 8.01,9.01

  18. 8-K · Current report

    Report date 2026-01-27 · 0001437749-26-002682 · Items 5.02

  19. 8-K · Current report

    Report date 2026-01-12 · 0001437749-26-001455 · Items 3.01,7.01,8.01,9.01

  20. 8-K · Current report

    Report date 2025-12-18 · 0001437749-25-038835 · Items 7.01,9.01

  21. 8-K · Current report

    Report date 2025-11-20 · 0001437749-25-036452 · Items 4.01,9.01

  22. 8-K/A · Current report

    Report date 2025-09-08 · 0001437749-25-036005 · Items 9.01

  23. 10-Q · Quarterly report

    Report date 2025-09-30 · 0001437749-25-035210

  24. 8-K · Current report

    Report date 2025-10-17 · 0001437749-25-031637 · Items 7.01,8.01,9.01

  25. 8-K · Current report

    Report date 2025-09-24 · 0001437749-25-029907 · Items 8.01,9.01

  26. 8-K · Current report

    Report date 2025-09-08 · 0001437749-25-028949 · Items 2.01,7.01,9.01

  27. 4 · Ownership change

    Report date 2025-04-09 · 0001415889-25-024084

  28. 4 · Ownership change

    Report date 2025-04-09 · 0001415889-25-024083

  29. 4 · Ownership change

    Report date 2025-04-09 · 0001415889-25-024082

  30. 4 · Ownership change

    Report date 2025-04-09 · 0001415889-25-024081

  31. 8-K · Current report

    Report date 2025-09-02 · 0001437749-25-028567 · Items 8.01,9.01

  32. 8-K · Current report

    Report date 2025-08-18 · 0001437749-25-027256 · Items 1.01,2.02,7.01,9.01

  33. 10-Q · Quarterly report

    Report date 2025-06-30 · 0001437749-25-027167

  34. 8-K · Current report

    Report date 2025-08-11 · 0001437749-25-027059 · Items 8.01,9.01

  35. 8-K · Current report

    Report date 2025-06-05 · 0001437749-25-019803 · Items 8.01,9.01

  36. 8-K · Current report

    Report date 2025-05-15 · 0001437749-25-018000 · Items 2.02,7.01,9.01

  37. 10-Q · Quarterly report

    Report date 2025-03-31 · 0001437749-25-017252

  38. 4 · Ownership change

    Report date 2025-02-07 · 0001415889-25-003585

  39. 4 · Ownership change

    Report date 2024-12-17 · 0001415889-24-029694

  40. 4 · Ownership change

    Report date 2023-08-30 · 0001415889-23-013139

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-10-15 · 2026 Q3: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 0 transaction rows0SGrant / award: 0 transaction rows0AExercise / conversion: 0 transaction rows0MTax / exercise payment: 0 transaction rows0FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

0 matching transaction rows.

No matching transaction rows in the covered quarter. This does not establish that no insider transactions occurred.

Identity & relationships

Wikidata structured data · retrieved 2026-10-15 · 1663 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0001719406NRX Pharmaceuticals, Inc.

No parent relationship is available in this import; this is not proof of independence.

No verified LEI join available.

GLEIF legal entity reference data · retrieved 2026-10-15 · 1199 checked identities; 0 unavailable records

Search names and former names
  • Big Rock Partners Acquisition Corp. · former SEC name · 2017-10-13 to 2021-05-24

Revenue in constant purchasing power

USD revenue expressed in 2026-09 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

Year endedReported USD revenueCPI-adjusted USD revenue
2024-12-31$0$0
2023-12-31$0$0

Bureau of Labor Statistics · retrieved 2026-10-20 · 9 selected series; gaps remain missing

Explore the CPI history ↗